 | • レポートコード：MRC2303A068 • 出版社/出版日：Persistence Market Research / 2022年12月20日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,140,000 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,590,000 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社発行の当調査レポートでは、世界の化学発光イムノアッセイ（CLIA）市場の現状について調査・分析し、エグゼクティブサマリー、市場概要、市場リスク・動向分析、市場背景、主要成功要因、市場需要分析、市場価値分析、市場構造分析、競争分析、仮定、調査手法などの構成でまとめております。セグメント分析では、製品別（機器、消耗品、ソフトウェア＆サービス）、用途別（治療薬モニタリング、腫瘍、心臓病、内分泌、その他）、エンドユーザー別（病院、臨床検査室、製薬＆バイオテクノロジー企業、その他）、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東/アフリカ）の情報が含まれています。なお、当市場の主要企業には、DiaSorin S.p.A.、Abbott Laboratories、Shenzhen Mindray Bio-Medical Electronics Co., Ltd.、Immunodiagnostic Systems、Siemens Healthineers、Beckman Coulter Inc.、F. Hoffmann-La Roche AG、Inova Diagnostics, Inc.、Maccura Biotechnology Co., Ltd.、Ortho Clinical Diagnosticsなどが含まれています。 ・エグゼクティブサマリー ・市場概要 ・市場リスク・動向分析 ・市場背景 ・主要成功要因 ・市場需要分析 ・市場価値分析 ・世界の化学発光イムノアッセイ（CLIA）市場規模：製品別 - 機器の市場規模 - 消耗品の市場規模 - ソフトウェア＆サービスの市場規模 ・世界の化学発光イムノアッセイ（CLIA）市場規模：用途別 - 治療薬モニタリングにおける市場規模 - 腫瘍における市場規模 - 心臓病における市場規模 - 内分泌における市場規模 - その他用途における市場規模 ・世界の化学発光イムノアッセイ（CLIA）市場規模：エンドユーザー別 - 病院における市場規模 - 臨床検査室における市場規模 - 製薬＆バイオテクノロジー企業における市場規模 - その他エンドユーザーにおける市場規模 ・世界の化学発光イムノアッセイ（CLIA）市場規模：地域別 - 北米の化学発光イムノアッセイ（CLIA）市場規模 - 中南米の化学発光イムノアッセイ（CLIA）市場規模 - ヨーロッパの化学発光イムノアッセイ（CLIA）市場規模 - アジア太平洋の化学発光イムノアッセイ（CLIA）市場規模 - 中東/アフリカの化学発光イムノアッセイ（CLIA）市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Global Chemiluminescence Immunoassay Market: Global Industry Analysis 2017-2021 & Opportunity Assessment 2022-2032
A recent market study published by Persistence Market Research on the global Chemiluminescence Immunoassay market offers global industry analysis for 2017-2021 & opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical, as well as current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
The global Chemiluminescence Immunoassay market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.
By Product Type
Instruments
Automated
Semi-automated
Consumables
Software & Services
By Application
Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Disease
Autoimmune Disease
Other Applications
By End-use
Hospitals
Clinical Laboratories
Pharmaceutical & Biotechnology Companies
Other End-uses
By Region
North America
Europe
APAC
Middle East and Africa
Latin America
Report Chapters
Chapter 01 – Executive Summary
The executive summary of the global Chemiluminescence Immunoassay market includes the global market analysis, proprietary wheel of fortune, demand-side and supply-side trends, opportunity assessment, and recommendations on the global Chemiluminescence Immunoassay market.
Chapter 02 – Market Overview
Readers can find the detailed segmentation and definition of the global Chemiluminescence Immunoassay market in this chapter, which will help them understand basic information about the global Chemiluminescence Immunoassay market. This section also highlights the inclusions and exclusions, which help the reader to understand the scope of the global Chemiluminescence Immunoassay market report.
Chapter 03 – Market Background
The associated industry assessment of the global Chemiluminescence Immunoassay market is carried out in this section. In addition, this chapter explains key macroeconomic factors that are expected to influence the growth of the global Chemiluminescence Immunoassay market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the market. It offers provides key market dynamics of the global Chemiluminescence Immunoassay market, which include drivers, restraints, and opportunities. Moreover, it will help readers understand key trends followed by leading manufacturers in the global Chemiluminescence Immunoassay market.
Chapter 04 – Global Chemiluminescence Immunoassay Market Analysis 2017-2021 and Forecast, 2022-2032
This section provides detailed analysis of the historical global Chemiluminescence Immunoassay market Value, along with an opportunity analysis of the future. Readers can also find the incremental opportunity for the current year (2021–2022) and an absolute opportunity for the forecast period (2022–2032).
Chapter 05 – Global Chemiluminescence Immunoassay Market Analysis 2017-2021 and Forecast 2022-2032, by Product Type
Based on Product Types, the global Chemiluminescence Immunoassay market is segmented into (Instruments: Automated, Semi-automated; Consumables, Software & Services). In this chapter, readers can find market attractiveness analysis, based on Product Types.
Chapter 06 – Global Chemiluminescence Immunoassay Market Analysis 2017-2021 and Forecast 2022-2032, by Application
Based on Application, the global Chemiluminescence Immunoassay market is segmented into Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease and Other Applications. In this chapter, readers can find market attractiveness analysis, based on Application.
Chapter 07 – Global Chemiluminescence Immunoassay Market Analysis 2017-2021 and Forecast 2022-2032, by End-use
Based on End-use, the global Chemiluminescence Immunoassay market is segmented into Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies and Other End-uses. In this chapter, readers can find market attractiveness analysis, based on End-use.
Chapter 08 – Global Chemiluminescence Immunoassay Market Analysis 2017-2021 and Opportunity Assessment 2022-2032 by Region
This chapter explains how the global Chemiluminescence Immunoassay market will grow across various geographic regions, such as North America, Latin America, Europe, APAC and the Middle East and Africa (MEA).
Chapter 09 – North America Global Chemiluminescence Immunoassay Market market Analysis 2017-2021 & Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the global Chemiluminescence Immunoassay market in the North America region, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find regional trends, opportunities, and market growth based on Product Types, End use, and countries in the North America region.
Chapter 10 – Latin America Global Chemiluminescence Immunoassay Market Analysis 2017-2021 & Forecast 2022-2032
Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the global Chemiluminescence Immunoassay market in the Latin America region. This chapter also includes growth prospects of the global Chemiluminescence Immunoassay market in leading LATAM countries such as Brazil, Argentina and Mexico.
Chapter 11 – Europe Global Chemiluminescence Immunoassay Market Analysis 2017-2021 & Forecast 2022-2032
Important growth prospects of the global Chemiluminescence Immunoassay market based on its product type, price, and sales channel in several countries such as Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe are included in this chapter.
Chapter 12 – APAC Global Chemiluminescence Immunoassay Market Analysis 2017-2021 & Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the global Chemiluminescence Immunoassay market in the South Asia region, along with a country-wise assessment that includes, China, Japan, Singapore and South Korea. Readers can also find regional trends, restraints, and market growth of countries in the APAC region.
Chapter 13 – Middle East and Africa Global Chemiluminescence Immunoassay Market Analysis 2017-2021 & Forecast 2022-2032
This chapter offers insights into how the global Chemiluminescence Immunoassay market is expected to grow in major countries in the MEA region such as Saudi Arabia, South Africa, and the UAE, during the forecast period 2022-2032.
Chapter 14 – Key Countries Chemiluminescence Immunoassay Market Analysis
This chapter offers insights into how the global Chemiluminescence Immunoassay market is expected to grow in key countries in the such as U.S., Canada, Brazil, Argentina, Mexico, Germany, U.K., France, Italy, Spain, Rest of Europe, China, Japan, Singapore, South Korea, Saudi Arabia, South Africa, and UAE during the forecast period 2022-2032.
Chapter 15 – Market Structure Analysis
In this chapter, readers can find detailed information about tier analysis and market concentration of the key players in the global Chemiluminescence Immunoassay market along with their market presence analysis by region and product portfolio.
Chapter 16 – Competition Deep-Dive Analysis
In this chapter, readers can find a comprehensive list of manufacturers/ players in the global Chemiluminescence Immunoassay market, along with detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the key players in Chemiluminescence Immunoassay market include DiaSorin S.p.A., Abbott Laboratories, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Immunodiagnostic Systems, Siemens Healthineers, Beckman Coulter Inc., F. Hoffmann-La Roche AG among others.
Chapter 17 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a based to the information and statistics included in the global Chemiluminescence Immunoassay market report.
Chapter 18 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on the global Chemiluminescence Immunoassay market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Chemiluminescence Immunoassay
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Bn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Chemiluminescence Immunoassay Market, by Key Countries
4.2. Chemiluminescence Immunoassay Market Opportunity Assessment (US$ Bn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors – Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Patch Management Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Patch Management Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Chemiluminescence Immunoassay Market Demand Analysis 2017-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2017-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Chemiluminescence Immunoassay Market Value Analysis 2017-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Bn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$ Bn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Chemiluminescence Immunoassay Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Product Type, 2017-2021
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product Type, 2022-2032
8.3.1. Instruments
8.3.1.1. Automated
8.3.1.2. Semi-automated
8.3.2. Consumables
8.3.3. Software & Services
8.4. Market Attractiveness Analysis By Product Type
9. Global Chemiluminescence Immunoassay Market Analysis 2017-2021 and Forecast 2022-2032, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By Application, 2017-2021
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2022-2032
9.3.1. Therapeutic Drug Monitoring
9.3.2. Oncology
9.3.3. Cardiology
9.3.4. Endocrinology
9.3.5. Infectious Disease
9.3.6. Autoimmune Disease
9.3.7. Other Applications
9.4. Market Attractiveness Analysis By Application
10. Global Chemiluminescence Immunoassay Market Analysis 2017-2021 and Forecast 2022-2032, By End-use
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis By End-use, 2017-2021
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End-use, 2022-2032
10.3.1. Hospitals
10.3.2. Clinical Laboratories
10.3.3. Pharmaceutical & Biotechnology Companies
10.3.4. Other End-uses
10.4. Market Attractiveness Analysis By End-use
11. Global Chemiluminescence Immunoassay Market Analysis 2017-2021 and Forecast 2022-2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Bn) Analysis By Region, 2017-2021
11.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2022-2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Chemiluminescence Immunoassay Market Analysis 2017-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
12.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By Product Type
12.4.3. By End-use
12.4.4. By Application
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By End-use
12.5.4. By Application
13. Latin America Chemiluminescence Immunoassay Market Analysis 2017-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
13.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Product Type
13.4.3. By End-use
13.4.4. By Application
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By End-use
13.5.4. By Application
14. Europe Chemiluminescence Immunoassay Market Analysis 2017-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
14.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. U.K.
14.4.1.4. Italy
14.4.1.5. Spain
14.4.1.6. Russia
14.4.1.7. Rest of Europe
14.4.2. By Product Type
14.4.3. By End-use
14.4.4. By Application
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By End-use
14.5.4. By Application
15. Asia Pacific Chemiluminescence Immunoassay Market Analysis 2017-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
15.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Rest of Asia Pacific
15.4.2. By Product Type
15.4.3. By End-use
15.4.4. By Application
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By End-use
15.5.4. By Application
16. Middle East and Africa Chemiluminescence Immunoassay Market Analysis 2017-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021
16.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. Saudi Arabia
16.4.1.2. South Africa
16.4.1.3. UAE
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Product Type
16.4.3. By End-use
16.4.4. By Application
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By End-use
16.5.4. By Application
17. Key Countries Chemiluminescence Immunoassay Market Analysis 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Chemiluminescence Immunoassay Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.2.2.1. By Product Type
17.2.2.2. By End-use
17.2.2.3. By Application
17.3. Canada Chemiluminescence Immunoassay Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.3.2.1. By Product Type
17.3.2.2. By End-use
17.3.2.3. By Application
17.4. Mexico Chemiluminescence Immunoassay Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.4.2.1. By Product Type
17.4.2.2. By End-use
17.4.2.3. By Application
17.5. Brazil Chemiluminescence Immunoassay Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.5.2.1. By Product Type
17.5.2.2. By End-use
17.5.2.3. By Application
17.6. Germany Chemiluminescence Immunoassay Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.6.2.1. By Product Type
17.6.2.2. By End-use
17.6.2.3. By Application
17.7. France Chemiluminescence Immunoassay Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.7.2.1. By Product Type
17.7.2.2. By End-use
17.7.2.3. By Application
17.8. Italy Chemiluminescence Immunoassay Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.8.2.1. By Product Type
17.8.2.2. By End-use
17.8.2.3. By Application
17.9. Spain Chemiluminescence Immunoassay Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.9.2.1. By Product Type
17.9.2.2. By End-use
17.9.2.3. By Application
17.10. UK Chemiluminescence Immunoassay Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.10.2.1. By Product Type
17.10.2.2. By End-use
17.10.2.3. By Application
17.11. Russia Chemiluminescence Immunoassay Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.11.2.1. By Product Type
17.11.2.2. By End-use
17.11.2.3. By Application
17.12. China Chemiluminescence Immunoassay Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.12.2.1. By Product Type
17.12.2.2. By End-use
17.12.2.3. By Application
17.13. Japan Chemiluminescence Immunoassay Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.13.2.1. By Product Type
17.13.2.2. By End-use
17.13.2.3. By Application
17.14. South Korea Chemiluminescence Immunoassay Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.14.2.1. By Product Type
17.14.2.2. By End-use
17.14.2.3. By Application
17.15. Saudi Arabia Chemiluminescence Immunoassay Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.15.2.1. By Product Type
17.15.2.2. By End-use
17.15.2.3. By Application
17.16. South Africa Chemiluminescence Immunoassay Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.16.2.1. By Product Type
17.16.2.2. By End-use
17.16.2.3. By Application
17.17. UAE Chemiluminescence Immunoassay Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2017-2032
17.17.2.1. By Product Type
17.17.2.2. By End-use
17.17.2.3. By Application
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. DiaSorin S.p.A.
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. Abbott Laboratories
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. Immunodiagnostic Systems
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. Siemens Healthineers
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. Beckman Coulter Inc.
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Strategy Overview
19.3.7. F. Hoffmann-La Roche AG
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Strategy Overview
19.3.8. Inova Diagnostics, Inc.
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Strategy Overview
19.3.9. Maccura Biotechnology Co., Ltd.
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Sales Footprint
19.3.9.4. Strategy Overview
19.3.10. Ortho Clinical Diagnostics
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Sales Footprint
19.3.10.4. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology